Literature DB >> 8385355

Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells.

R A Cruciani1, B Dvorkin, S A Morris, S M Crain, M H Makman.   

Abstract

Evidence is presented for linkage of opioid receptors directly to the stimulatory G protein (guanine nucleotide-binding protein), Gs, in addition to the generally accepted linkage to the inhibitory and "other" G proteins, gi and Go, in F-11 (neuroblastoma-dorsal root ganglion neuron) hybrid cells. Treatment of intact F-11 cells with cholera toxin decreased specific binding of the opioid agonist [D-Ala2,D-Leu5]enkephalin to F-11 cell membranes by 35%, with the remaining binding retaining high affinity for agonist. Under these conditions cholera toxin influenced the alpha subunit of Gs (Gs alpha) but had no effect on the alpha subunit of Gi/o (Gi/o alpha), based on ADP-ribosylation studies. Pertussis toxin treatment decreased high-affinity opioid agonist binding by about 50%; remaining binding was also of high affinity, even though pertussis toxin had inactivated Gi/o alpha selectively and essentially completely. Simultaneous treatment with both toxins had an additive effect, reducing specific binding by about 80%. While opioid agonists inhibited forskolin-stimulated adenylate cyclase activity of F-11 cells as expected, opioids also stimulated basal adenylate cyclase activity, indicative of interaction with Gs as well as Gi. Cholera toxin treatment attenuated opioid-stimulation of basal adenylate cyclase, whereas pertussis toxin treatment enhanced stimulation. In contrast, inhibition by opioid of forskolin-stimulated activity was attenuated by pertussis toxin but not by cholera toxin. It is concluded that a subset of opioid receptors may be linked directly to Gs and thereby mediate stimulation of adenylate cyclase. This Gs-adenylate cyclase interaction is postulated to be responsible for the novel excitatory electrophysiologic responses to opioids found in our previous studies of sensory neurons and F-11 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385355      PMCID: PMC46228          DOI: 10.1073/pnas.90.7.3019

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  G proteins in signal transduction.

Authors:  L Birnbaumer
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

Review 2.  Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons.

Authors:  S M Crain; K F Shen
Journal:  Trends Pharmacol Sci       Date:  1990-02       Impact factor: 14.819

3.  Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures.

Authors:  S M Crain; B Crain; M H Makman
Journal:  Brain Res       Date:  1987-01-01       Impact factor: 3.252

4.  Modification of opioid agonist binding by pertussis toxin.

Authors:  M E Abood; N M Lee; H H Loh
Journal:  Brain Res       Date:  1987-08-04       Impact factor: 3.252

5.  Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.

Authors:  R A Cruciani; R A Lutz; P J Munson; D Rodbard
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

6.  Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture.

Authors:  K F Shen; S M Crain
Journal:  Brain Res       Date:  1989-07-10       Impact factor: 3.252

7.  Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.

Authors:  J A Clark; L Liu; M Price; B Hersh; M Edelson; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

8.  Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin.

Authors:  M H Makman; B Dvorkin; S M Crain
Journal:  Brain Res       Date:  1988-04-05       Impact factor: 3.252

9.  Myocardial adenylate cyclase activity in acute murine Chagas' disease.

Authors:  S A Morris; H Tanowitz; S M Factor; J P Bilezikian; M Wittner
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

10.  The GTP-binding protein, Go, regulates neuronal calcium channels.

Authors:  J Hescheler; W Rosenthal; W Trautwein; G Schultz
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

View more
  22 in total

1.  kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.

Authors:  J A Gurwell; M J Duncan; K Maderspach; A Stiene-Martin; R P Elde; K F Hauser
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

2.  Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.

Authors:  G Wu; Z H Lu; P Alfinito; R W Ledeen
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 3.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 4.  Functional analysis of cloned opioid receptors in transfected cell lines.

Authors:  E T Piros; T G Hales; C J Evans
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 5.  Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence.

Authors:  S M Crain; K F Shen
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 6.  Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results.

Authors:  Y Sarne; A Fields; O Keren; M Gafni
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  Methods Enzymol       Date:  2017-07-19       Impact factor: 1.600

8.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.

Authors:  Meritxell Llorca-Torralba; Fuencisla Pilar-Cuéllar; Lidia Bravo; Cristina Bruzos-Cidon; María Torrecilla; Juan A Mico; Luisa Ugedo; Emilio Garro-Martínez; Esther Berrocoso
Journal:  Mol Neurobiol       Date:  2018-10-03       Impact factor: 5.590

10.  G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb.

Authors:  Pierluigi Onali; Maria C Olianas
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.